Abstract
Development of an effective vaccine against cryptosporidiosis is a medical and veterinary priority. However, many putative Cryptosporidium vaccine candidates such as surface and apical complex antigens are posttranslationally modified with O- and N-linked glycans. This presents a significant challenge to understanding the functions of these antigens and the immune responses to them. Isolation of large amounts of native antigen from Cryptosporidium oocysts is expensive and is only feasible for C. parvum antigens. Here, we describe a method of producing recombinant, functional Cryptosporidium glycoprotein antigens in Toxoplasma gondii. These functional recombinant proteins can be used to investigate the role of glycotopes in Cryptosporidium immune responses and parasite–host cell interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Riggs MW, Stone AL, Yount PA, Langer RC, Arrowood MJ, Bentley DL (1997) Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J Immunol 158(4):1787–1795
Cevallos AM, Zhang X, Waldor MK, Jaison S, Zhou X, Tzipori S, Neutra MR, Ward HD (2000) Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun 68(7):4108–4116
Perryman LE, Jasmer DP, Riggs MW, Bohnet SG, McGuire TC, Arrowood MJ (1996) A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol Biochem Parasit 80(2):137–147
Barnes DA, Bonnin A, Huang JX, Gousset L, Wu J, Gut J, Doyle P, Dubremetz JF, Ward H, Petersen C (1998) A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol Biochem Parasit 96(1–2):93–110
Priest JW, Kwon JP, Arrowood MJ, Lammie PJ (2000) Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol Biochem Parasit 106(2):261–271
Paluszynski J, Monahan Z, Williams M, Lai O, Morris C, Burns P, O’Connor R (2014) Biochemical and functional characterization of CpMuc4, a Cryptosporidium surface antigen that binds to host epithelial cells. Mol Biochem Parasit 193(2):114–121. https://doi.org/10.1016/j.molbiopara.2014.03.005
Cevallos AM, Bhat N, Verdon R, Hamer DH, Stein B, Tzipori S, Pereira ME, Keusch GT, Ward HD (2000) Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun 68(9):5167–5175
Vinayak S, Pawlowic MC, Sateriale A, Brooks CF, Studstill CJ, Bar-Peled Y, Cipriano MJ, Striepen B (2015) Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. Nature 523(7561):477–480. https://doi.org/10.1038/nature14651
DeCicco RePass MA, Chen Y, Lin Y, Zhou W, Kaplan DL, Ward HD (2017) Novel bioengineered three-dimensional human intestinal model for long-term infection of Cryptosporidium parvum. Infect Immun 85(3). https://doi.org/10.1128/IAI.00731-16
Heo I, Dutta D, Schaefer DA, Iakobachvili N, Artegiani B, Sachs N, Boonekamp KE, Bowden G, Hendrickx APA, Willems RJL, Peters PJ, Riggs MW, O’Connor R, Clevers H (2018) Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nature Microbiol 3(7):814–823. https://doi.org/10.1038/s41564-018-0177-8
Morada M, Lee S, Gunther-Cummins L, Weiss LM, Widmer G, Tzipori S, Yarlett N (2016) Continuous culture of Cryptosporidium parvum using hollow fiber technology. Int J Parasitol 46(1):21–29. https://doi.org/10.1016/j.ijpara.2015.07.006
O’Connor RM, Wanyiri JW, Wojczyk BS, Kim K, Ward H (2007) Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in toxoplasma gondii. Mol Biochem Parasitol 152(2):149–158
O'Connor RM, Kim K, Khan F, Ward H (2003) Expression of Cpgp40/15 in Toxoplasma gondii: a surrogate system for the study of Cryptosporidium glycoprotein antigens. Infect Immun 71:6027–6034
Roos DS, Donald RG, Morrissette NS, Moulton AL (1994) Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol 45:27–63
Khan A, Grigg ME (2017) Toxoplasma gondii: laboratory maintenance and growth. Curr Protoc Microbiol 44:20C 21 21–20C 21 17. https://doi.org/10.1002/cpmc.26
Meissner M, Brecht S, Bujard H, Soldati D (2001) Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii. Nucleic Acids Res 29(22):E115
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Driskell, I., O’Connor, R.M. (2020). Production and Purification of Functional Cryptosporidium Glycoproteins by Heterologous Expression in Toxoplasma gondii. In: Mead, J., Arrowood, M. (eds) Cryptosporidium. Methods in Molecular Biology, vol 2052. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9748-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9748-0_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9747-3
Online ISBN: 978-1-4939-9748-0
eBook Packages: Springer Protocols